Answers are grounded in this paper and cite their sources.
The tumor microenvironment (TME) significantly restricts chemodynamic therapy (CDT) efficacy through hypoxia and antioxidant defenses. An intelligent cascade nanosystem, PTA‐SnS 2 @GOx, is developed by integrating a tannic acid‐modified Prussian blue analogue core, SnS 2 shell, and glucose oxidase (GOx) activation module. The needle‐like nanostructure enhanced tumor accumulation and cellular uptake. GOx‐mediated glucose oxidation generated H 2 O 2 and gluconic acid, triggering pH‐responsive H 2 S release from SnS 2 . This gas disrupted mitochondrial respiration and catalase activity, alleviating hypoxia while elevating intracellular H 2 O 2 levels. The oxygenated TME subsequently amplified GOx biocatalysis, establishing a self‐sustaining cycle of H 2 O 2 production and acidification. Concurrently, Sn 4+ ions depleted glutathione, synergistically enhancing Fenton‐like reactions in the PTA core for reinforced ROS generation. This multi‐tiered strategy achieved effective CDT through the coordinated mechanisms: continuous H 2 O 2 self‐supply, pH reduction, and redox homeostasis disruption. Notably, the nanosystem induced immunogenic cell death, promoting dendritic cell maturation and repolarizing tumor‐associated macrophages from M2 to M1 phenotype, thereby remodeling immunosuppressive TME and activating systemic antitumor immunity. The synergistic integration of self‐amplifying CDT with immune sensitization demonstrates superior tumor suppression in vivo. This study provided an intelligent paradigm for cancer theranostics by combining self‐supplying H 2 S/H 2 O 2 ‐enhanced CDT with sensitized immunotherapy.
No takes yet. Share an insight, caveat, or question.
Sun et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: